Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29

AIDS

Volumn 11, Issue 11, 1997, Pages 1311-1318

  Delézay, Olivier ^a   Koch, Nathalie ^b   Yahi, Nouara ^b   Hammache, Djilali ^a   Tourres, Christian ^b   Tamalet, Catherine ^b   Fantini, Jacques ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

CD4; Coreceptor; Fusin; Fusion; Galactosylceramide; Glycolipids; Intestinal cells

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; GALACTOSYLCERAMIDE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; VIRUS RECEPTOR;

ARTICLE; CELL LINE; CELL STRAIN CACO 2; CELL SURFACE; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTESTINE EPITHELIUM CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS INHIBITION;

ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; CACO-2 CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA, VIRAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GALACTOSYLCERAMIDES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTESTINAL MUCOSA; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; RECEPTORS, CXCR4; RECEPTORS, HIV; SULFOGLYCOSPHINGOLIPIDS;

EID: 0030767645     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199711000-00004     Document Type: Article

References (33)

1. Bour S, Geleziunas R, Wainberg MA: The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev 1995, 59:63-93.
2. Harouse JM, Bhat S, Spitalnik SL, et al.: Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991, 253:320-321.
3. Yahi N, Baghdiguian S, Moreau H, Fantini J: Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT-29 cells. J Virol 1992, 66:4848-4854.
4. Fantini J, Cook DG, Nathanson N, Spitalnik SL, Gonzalez-Scarano F: Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus (HIV-1) is associated with cell surface expression of galactosyl ceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci USA 1993, 90:2700-2704.
5. Harouse IM, Collman R, Gonzalez-Scarano F: Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3′ sulfo-galactosyl ceramide-positive cell line. J Virol 1995, 69:7380-7390.
6. Bhat S, Spitalnik SL, Gonzalez-Scarano F, Silverberg DH: Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci USA 1991, 88:7131-7134.
7. Long D, Berson JF, Cook DG, Doms RW: Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide. J Virol 1994, 68:5890-5898.
8. Yahi N, Sabatier IM, Nickel P, Mabrouk K, Gonzalez-Scarano F, Fantini J: Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. J Biol Chem 1994, 269:24349-24353.
9. Yahi N, Spitalnik SL, Stefano KA, De Micco P, Gonzalez-Scarano F, Fantini J: Interferon-γ decreases cell surface expression of galactosylceramide, the receptor for HIV-1 gp120 on human colonic epithelial cells. Virology 1994, 204:550-557.
10. Cook DG, Fantini J, Spitalnik SL, Gonzalez-Scarano F: Binding of human immunodeficiency virus type 1 (HIV-1) gp120 to galactosylceramide (GalCer): relationship to the V3 loop. Virology 1994, 201:206-214.
11. Yahi N, Sabatier JM, Baghdiguian S, Gonzalez-Scarano F, Fantini J: Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp 120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J Virol 1995, 69:320-325
12. Bhat S, Mettus RV, Reddy EP, et al.: The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res Hum Retrovirus 1993, 9:175-181.
13. Feng Y, Broder CC, Kenedy PE, Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G-proteincoupled receptor. Science 1996, 272:872-877.
14. Berson JF, Long D, Doranz BJ, Rucker J, Jirik FR, Doms RW: A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol 1996, 70:6288-6295.
15. Sattentau QJ, Moore JP: Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991, 174:407-415.
16. Lapham CL, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H: Evidence for cell surface association between fusin and the CD4-gp120 complex in human cell lines. Science 1996, 274:602-605.
17. Wu L, Gerard NP, Wyatt R, et al.: CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996, 384:179-183.
18. Trkola A, Dragk T, Arthos I, et al: CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996, 384:184-187.
19. Endres MJ, Clapham PR, Marsh M. et al.: CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996, 87:745-756.
20. Barré-Sinoussi F, Chermann JC, Rey F, et al.: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome. Science 1983, 220:868-870.
21. Ellrodt A, Barré-Sinoussi F, Le Bras F, et al.: Isolation of a new human T-lymphotropic retrovirus (LAV) from a married couple of Zairians, one with AIDS, the other with prodromes. Lancet 1984, i:1383-1385.
22. Collman R, Balliet JW, Gregory SA, et al.: An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of the human immunodeficiency virus type 1. J Virol 1992, 66:7517-7521.
23. Fantini I, Yahi N, Delézay O, Gonzalez-Scarano F: GalCer, CD26 and HIV infection of intestinal epithelial cells [letter]. AIDS 1994, 8:1347-1348.
24. Rantsch B, Clapshaw PA, Price I, Noble M, Seifert W: Development of oligodendrocyte and Schwann cells studied with a monoclonal antibody against galactocerebroside. Proc Natl Acad Sci USA 1982, 79:2936-2939.
25. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE: Multiple and novel specificities of monoclonal O1, O4, and R-MAb used in the analysis of oligodendrocyte development. J Neurosci Res 1989, 24:548-557.
26. Doranz BJ, Rucker J, Yi Y, et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the b-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85:1149-1158.
27. McKnight A, Wilkinson D, Simmons G, et al.: Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol 1997, 71:1692-1696.
28. Albright AV, Strizki J, Harouse JM, Lavi E, O'Connor M, Gonzalez-Scarano F: HIV-1 infection of cultured human adult oligodendrocytes. Virology 1996, 217:211-219.
29. Baccetti B, Benedetto A, Burrini AG, et al.: HIV-particles in spermatozoa of patients with AIDS and their transfer into the oocyte. J Cell Biol 1994, 127:903-914.
30. Furuta Y, Eriksson K, Svennerholm B, et al.: Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci USA 1994, 91:12559-12563.
31. D'Souza MP, Harden VA: Chemokines and HIV-1 second receptors. Confluence of two fields generate optimism in AIDS research. Nature Med 1996, 2:1293-1300.
32. Yahi N, Ratner L, Harouse JM, Gonzalez-Scarano F, Fantini J: Genetic determinants controlling HIV-1 tropism for CD4-/GalCer+ human intestinal epithelial cells. Perspect Drug Discov Des 1996, 5:159-166.
33. Simmons G, Wilkinson D, Reeves JD, et al.: Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996, 70:8355-8360.